방사선종양학

본문글자크기
  • [Front Oncol.] Efficacy of Whole-Ventricular Radiotherapy in Patients Undergoing Maximal Tumor Resection for Glioblastomas Involving the Ventricle

    연세의대 / 김경환, 장종희*, 윤홍인*

  • 출처
    Front Oncol.
  • 등재일
    2021 Sep 21
  • 저널이슈번호
    11:736482. doi: 10.3389/fonc.2021.736482. eCollection 2021.
  • 내용

    바로가기  >

    Abstract
    Background and purpose: Patients with glioblastoma (GBM) involving the ventricles are at high risk of ventricle opening during surgery and potential ventricular tumor spread. We evaluated the effectiveness of whole-ventricular radiotherapy (WVRT) in reducing intraventricular seeding in patients with GBM and identified patients who could benefit from this approach.

    Methods and materials: We retrospectively reviewed the data of 382 patients with GBM who underwent surgical resection and temozolomide-based chemoradiotherapy. Propensity score matching was performed to compensate for imbalances in characteristics between patients who did [WVRT (+); n=59] and did not [WVRT (-); n=323] receive WVRT. Local, outfield, intraventricular, and leptomeningeal failure rates were compared.

    Results: All patients in the WVRT (+) group had tumor ventricular involvement and ventricle opening during surgery. In the matched cohort, the WVRT (+) group exhibited a significantly lower 2-year intraventricular failure rate than the WVRT (-) group (2.1% vs. 11.8%; P=0.045), with no difference in other outcomes. Recursive partitioning analysis stratified the patients in the WVRT (-) group at higher intraventricular failure risk (2-year survival, 14.2%) due to tumor ventricular involvement, MGMT unmethylation, and ventricle opening. WVRT reduced the intraventricular failure rate only in high-risk patients (0% vs. 14.2%; P=0.054) or those with MGMT-unmethylated GBM in the matched cohort (0% vs. 17.3%; P=0.036).

    Conclusions: WVRT reduced the intraventricular failure rate in patients with tumor ventricular involvement and ventricle opening during surgery. The MGMT-methylation status may further stratify patients who could benefit from WVRT. Further prospective evaluation of WVRT in GBM is warranted.

     

     

    Affiliations

    Kyung Hwan Kim 1, Jihwan Yoo 2, Nalee Kim 3, Ju Hyung Moon 2, Hwa Kyung Byun 1, Seok-Gu Kang 2, Jong Hee Chang 2, Hong In Yoon 1, Chang-Ok Suh 1 4
    1Department of Radiation Oncology, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, South Korea.
    2Department of Neurosurgery, Yonsei University College of Medicine, Seoul, South Korea.
    3Department of Radiation Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.
    4Department of Radiation Oncology, CHA Bundang Medical Center, CHA University, Seongnam, South Korea.

  • 키워드
    MGMT; glioblastoma; radiotherapy; temozolomide; ventricle.
  • 덧글달기
    덧글달기
       IP : 3.236.138.35

    등록